Clinical Trial Update: Non-Pharmacologic Therapy for Neurocardiogenic Syncope [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating non-pharmacologic therapy for neurocardiogenic syncope (vasovagal syncope) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syncope
• Vasovagal Syncope

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Syncope | Phase 2 | Status: COMPLETED